Article
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.
Blood - 1 Mar 2007
Al-toma Abdulbaqi, Visser Otto J, van Roessel Hyacintha M, von Blomberg B Mary E, Verbeek Wieke H M, Scholten Petra E T, Ossenkoppele Gert J, Huijgens Peter C, Mulder Chris J J
Abstract excerpt
Autologous hematopoietic stem cell transplantation (ASCT) is an increasingly accepted treatment for refractory autoimmune diseases. Refractory celiac disease with aberrant T cells (RCD type II) is unresponsive to available therapies and carries a high risk of transition into enteropathy associated T-cell lymphoma (EATL). This study reports on the feasibility, safety, and efficacy of ASCT in patients with RCD type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.